Publications
93
Citations
1,009
Est. group size
~3
Recurring co-author estimate
Active years
10
Publishing since 2017
Tarek Haykal's work centers on melanoma and other cancers, focusing on immunotherapy (such as checkpoint inhibitors like PD-1/PD-L1 blockers), treatment outcomes, and factors that predict how patients respond to treatment. Recent projects also examine quality-of-life issues for cancer patients, including fertility concerns in young adults and psychological support during treatment. The work spans clinical case reports, retrospective outcome studies, and translational research into the biological mechanisms of immunotherapy resistance.
Publication output peaked around 2018-2019, declined through the early 2020s, and has shown a modest, steady pace of roughly 6-8 papers per year in recent years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- High-Risk Acute Myeloid Leukemia Developing in a Patient with Recurrent Melanoma: A Case Report
Case Reports in Oncology · 2026
- Expressive writing for body image distress and anxiety in adolescent and young adult cancer survivors: A pilot, randomized controlled trial.
Journal of Clinical Oncology · 2026
- Vaccines in Melanoma
Surgical Oncology Clinics of North America · 2025
- Neoadjuvant treatment in advanced resectable melanoma and the need for a predictive biomarker - is pathologic complete response (pCR) the answer?
The American Journal of Surgery · 2025
- Identifying fertility concerns and needs among adolescent and young adult males with melanoma receiving immunotherapy: A qualitative analysis.
JCO Oncology Practice · 2025
- 725 Fertility concerns and outcomes among adolescent and young adult males with melanoma receiving immunotherapy
Regular and Young Investigator Award Abstracts · 2025
- Fertility Concerns and Outcomes Among Adolescent and Young Adult Males With Melanoma Receiving Immunotherapy: A Mixed‐Methods Study
Cancer Medicine · 2025
- Guide to Understanding and Supporting International Medical Graduates in Hematology/Oncology by the ASCO International Medical Graduates Community of Practice
JCO Oncology Practice · 2024
- Relationship of left ventricular diastolic dysfunction with quality of life in heart failure patients with reduced ejection fraction (HFrEF)
Narra J · 2024
- Prognostic factors and survival outcomes for pancreatic acinar cell carcinoma: retrospective analysis of the National Cancer Database
HPB · 2024
- Adjuvant PD-1-based therapies for high-risk resected melanomas are here to stay
The American Journal of Surgery · 2024
- Prognostic factors and clinical outcomes for pancreatic acinar cell carcinoma
HPB · 2024
- Patterns of care delivery and outcomes in patients with melanoma brain metastases treated with ipilimumab/nivolumab.
Journal of Clinical Oncology · 2023
- Tumor-intrinsic NLRP3-HSP70-TLR4 axis drives premetastatic niche development and hyperprogression during anti–PD-1 immunotherapy
Science Translational Medicine · 2022
- A Phase I Trial of SYK Inhibition with Fostamatinib in the Prevention and Treatment of Chronic Graft-Versus-Host Disease
Transplantation and Cellular Therapy · 2022
- Journal of Clinical Oncology×10
- Journal of Thrombosis and Thrombolysis×5
- Cureus×5
- Regular and Young Investigator Award Abstracts×5
- Journal of Community Hospital Internal Medicine Perspectives×4
- Lynn A. Witty
Medicine · Indiana University
- Lauren K. Stewart
Medicine · Indiana University
- Colin G. Kaide
Medicine · The Ohio State University
- Luke Baker
Medicine · The Ohio State University
- Mary Proctor
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile